Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19
Year: 2018
Type: article
Abstract: It has previously been reported that human adipose-derived stem cells (hASCs) can promote the regeneration of damaged tissues in rats with liver failure through a 'paracrine effect'. Here we demonstrate a therapeutic effect of hASCs derived Extracellular Vesicles (EVs) on rat models with acute liver failure, as shown by the improvement of the survival rate by >70% compared to controls. Gene sequencing of rat liver revealed an increase in human long-chain non-coding RNA (lncRNA) H19 after hASC-derived EVs transplantation. When the H19 coding sequence was silenced in hASCs and EVs were then collected for treatment of rats with liver failure, we saw a decrease in the survival rate to 40%, compared to treatment with EVs generated from non-silenced hASCs. These data indicate that lncRNA H19 may be a potential therapeutic target for the treatment of liver failure.
Source: EBioMedicine
Institutions: Fudan University, Shanghai Public Health Clinical Center, Chinese People 's Liberation Army No. 85 Hospital, Tongji University, Shanghai East Hospital, Shanghai Tenth People's Hospital, Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences, State Key Laboratory of Neuroscience, University of Sheffield
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,780
Funders: National Science Foundation, National Natural Science Foundation of China, Fudan University, Chinese Foundation for Hepatitis Prevention and Control, Nanjing Military Region Medical Scientific and Technical Innovation Foundation Projects of People’s Liberation Army of China, Major Scientific and Technological Special Project of Guizhou Province, Bijzonder Onderzoeksfonds UGent, Fundamental Research Funds for the Central Universities
OpenAlex ID: W2887684893
